MarketPulse — Real-Time Financial News & Market Analysis

Commodore Capital cuts $84M Nuvalent stake to 3.68% despite 29% stock gains. Biotech firm awaits September PDUFA decision for lead drug candidate.

The Honest Company relaunches plant-based sanitizing wipes with 99.99% germicidal efficacy across major retailers including Amazon and Target, featuring natural fragrances and 65% plant-derived alcohol.

Recyclable PE laminates market expected to double from $2.5B to $5.92B by 2035, driven by sustainability demand and stricter environmental regulations globally.

KBR wins Iraq Majnoon Field contract for integrated management services. The deal expands its Middle East upstream operations amid broader portfolio growth.

Affinius Capital consortium to acquire multifamily REIT Veris Residential for $3.4B, offering shareholders $19/share—a 23.2% premium.

Viewbix acquires 85-100% stake in Israel-based Quantum X Labs, gaining control of quantum research portfolio spanning gyroscopes, error correction, biomedical, cybersecurity, and nuclear technology.

Royal Caribbean achieved record 2025 earnings of $15.61 per share on $17.9 billion revenue, driven by strong demand and fleet expansion strategy targeting 20% annual earnings growth.

Microsoft, Alphabet, and Amazon offer defensive characteristics through recurring revenue and mission-critical services, potentially weathering market downturns better than broader indices.

Azul appoints aviation executive John Slattery to Strategy Committee as Brazil's largest airline exits bankruptcy and strengthens governance.

Merck restructures commercial operations into two divisions ahead of Keytruda's 2028 patent expiration, aiming to accelerate growth from 20+ pipeline candidates.

Three high-yield dividend stocks—AGNC, Ares Capital, and Western Midstream—offer yields of 8-12%, significantly exceeding market averages for income-seeking investors.

Supreme Court limits Trump's tariff authority, providing relief to retailers like Nike and Target facing margin pressures. Decision removes trade policy uncertainty but doesn't address broader business challenges.

Teva's once-monthly schizophrenia injection TEV-749 advances toward FDA approval, aiming to improve patient medication compliance and reduce healthcare burden compared to daily oral treatments.

CIBC Asset Management declared February 2026 distributions across 27 ETFs, with per-unit payments ranging from $0.021 to $0.155, payable March 4.

Marpai gains 19,000 covered lives through two major enterprise contracts for its pharmacy benefit management platform, with full operations expected in Q2 2026.

ASML repurchased 102,512 shares for €123.2 million during February 16-20, 2026, at prices ranging €1,181-€1,241 per share as part of ongoing capital returns.

Aligos presented clinical progress for hepatitis B and coronavirus treatments at CROI. Pevifoscorvir showed strong viral suppression, while ALG-097558 provided dosing data for impaired patients.

Getty Images and Shutterstock receive unconditional DOJ approval for merger. Companies expect cost synergies; UK regulatory clearance still pending by April 2026.

TOP Ships acquires nine eco tankers for $41M with $679M charter backlog secured through 2028-2029 deliveries, ensuring predictable revenue from long-term contracts.

Gilead acquires Arcellx for $7.8B to gain CAR-T therapy anito-cel for multiple myeloma, with FDA approval expected by late 2026.